Cara Therapeutic (CARA) Insider Trading
- $13,593,298.00
- $24,904,275.63
- May 2, 2024
- Frederique Ph.D. Menzaghi
| Trader Name | Date | Title | Amount | Price | Type | Total Value | 
|---|---|---|---|---|---|---|
| May 2, 2024 | CEO | 3,936 | $0.75 | Sell | $2,952.00 | |
| April 5, 2024 | Insider | 2,753 | $0.83 | Sell | $2,284.99 | |
| Feb. 8, 2024 | CFO | 5,488 | $0.53 | Sell | $2,908.64 | |
| Feb. 8, 2024 | CEO | 35,575 | $0.53 | Sell | $18,854.75 | |
| Feb. 8, 2024 | Insider | 7,770 | $0.53 | Sell | $4,118.10 | |
| Feb. 1, 2024 | CEO | 4,981 | $0.55 | Sell | $2,739.55 | |
| Nov. 2, 2023 | CEO | 3,796 | $1.22 | Sell | $4,631.12 | |
| Aug. 3, 2023 | CEO | 4,307 | $3.07 | Sell | $13,222.49 | |
| June 23, 2023 | Insider | 2,483 | $3.51 | Sell | $8,715.33 | |
| June 23, 2023 | SVP | 2,993 | $3.51 | Sell | $10,505.43 | |
| May 5, 2023 | CEO | 3,869 | $4.40 | Sell | $17,023.60 | |
| April 4, 2023 | Insider | 2,481 | $4.91 | Sell | $12,181.71 | |
| April 4, 2023 | SVP | 2,733 | $4.91 | Sell | $13,419.03 | |
| Feb. 2, 2023 | CEO | 4,191 | $11.80 | Sell | $49,453.80 | |
| Jan. 17, 2023 | Insider | 2,265 | $10.81 | Sell | $24,484.65 | |
| Dec. 21, 2022 | SVP | 3,506 | $11.27 | Sell | $39,512.62 | |
| Dec. 21, 2022 | Insider | 2,992 | $11.27 | Sell | $33,719.84 | |
| Nov. 16, 2022 | CEO | 14,470 | $11.13 | Sell | $161,051.10 | |
| Sept. 14, 2022 | Director | 10,800 | $10.28 | Sell | $111,024.00 | |
| July 15, 2022 | Director | 3,600 | $9.05 | Sell | $32,580.00 | |
| April 4, 2022 | CEO | 2,006 | $12.67 | Sell | $25,416.02 | |
| April 1, 2022 | Insider | 1,642 | $11.91 | Sell | $19,556.22 | |
| April 1, 2022 | SVP | 1,784 | $11.91 | Sell | $21,247.44 | |
| March 3, 2022 | Insider | 1,787 | $11.38 | Sell | $20,336.06 | |
| March 3, 2022 | CFO | 2,044 | $11.38 | Sell | $23,260.72 | |
| Feb. 25, 2022 | Insider | 1,972 | $10.29 | Sell | $20,291.88 | |
| Nov. 12, 2021 | Director | 8,180 | $16.04 | Sell | $131,207.20 | |
| Nov. 1, 2021 | Insider | 1,000 | $17.15 | Sell | $17,150.00 | |
| Oct. 27, 2021 | Insider | 1,000 | $15.00 | Sell | $15,000.00 | |
| Sept. 7, 2021 | CEO | 20,000 | $15.47 | Sell | $309,400.00 | |
| Aug. 30, 2021 | CFO | 1,982 | $14.20 | Sell | $28,144.40 | |
| Aug. 30, 2021 | SVP | 3,847 | $14.20 | Sell | $54,627.40 | |
| Aug. 30, 2021 | Insider | 1,759 | $14.20 | Sell | $24,977.80 | |
| Aug. 30, 2021 | CEO | 8,440 | $14.20 | Sell | $119,848.00 | |
| June 7, 2021 | Director | 8,640 | $13.05 | Sell | $112,752.00 | |
| April 21, 2021 | Insider | 3,000 | $27.63 | Sell | $82,890.00 | |
| March 22, 2021 | Insider | 3,000 | $19.65 | Sell | $58,950.00 | |
| March 5, 2021 | SVP | 3,358 | $17.98 | Sell | $60,376.84 | |
| March 5, 2021 | CEO | 3,103 | $17.98 | Sell | $55,791.94 | |
| March 5, 2021 | Insider | 3,090 | $17.98 | Sell | $55,558.20 | |
| Feb. 25, 2021 | CEO | 11,729 | $19.33 | Sell | $226,721.57 | |
| Feb. 25, 2021 | Insider | 4,004 | $19.33 | Sell | $77,397.32 | |
| Feb. 25, 2021 | SVP | 5,003 | $19.33 | Sell | $96,707.99 | |
| Jan. 21, 2021 | Insider | 2,000 | $20.12 | Sell | $40,240.00 | |
| Dec. 30, 2020 | CEO | 6,078 | $15.30 | Sell | $92,993.40 | |
| Dec. 30, 2020 | SVP | 2,812 | $15.30 | Sell | $43,023.60 | |
| Dec. 30, 2020 | Insider | 1,946 | $15.30 | Sell | $29,773.80 | |
| Dec. 28, 2020 | CEO | 5,000 | $16.00 | Sell | $80,000.00 | |
| Dec. 21, 2020 | Insider | 2,000 | $15.00 | Sell | $30,000.00 | |
| Dec. 16, 2020 | CEO | 5,000 | $14.95 | Sell | $74,750.00 | 
- Insiders are both buying and selling Cara Therapeutic stock. 
- The insider traders at Cara Therapeutic are: Frederique Ph.D. Menzaghi, Derek T Chalmers, Scott Terrillion, Joana Goncalves, Jeffrey L Ives, Christopher Posner, Mani Mohindru, Michael E Lewis, Ventures Vi Lp Rho, Martin Vogelbaum, Dean Slagel, Thomas Charles Reilly, Josef Schoell, Ryan D Maynard, Derek T. Chalmers, and Joseph William Stauffer 
- The most active insider trader at Cara Therapeutic is Frederique Ph.D. Menzaghi with 39 trades. 
- Dean Slagel has sold the most Cara Therapeutic stock with a total value of $14,826,886.22. 
- Ventures Vi Lp Rho has bought the most Cara Therapeutic stock with a total value of $22,621,998.00. 
- The most recent insider trade for Cara Therapeutic was on May 2, 2024. 
- The single biggest insider buy for Cara Therapeutic was from Ventures Vi Lp Rho with a total value of $9,095,000.00 on March 31, 2017. 
- The single biggest insider sell for Cara Therapeutic was from Dean Slagel with a total value of $6,467,500.00 on June 29, 2017. 
